Stay updated on Subcutaneous Atezolizumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Subcutaneous Atezolizumab in NSCLC Clinical Trial page.

Latest updates to the Subcutaneous Atezolizumab in NSCLC Clinical Trial page
- Check3 days agoChange DetectedRecruitment status updated to no longer seek participants, indicating enrollment has ended. The study record shows a new revision (v3.6.0) replacing the previous version (v3.5.5).SummaryDifference0.4%

- Check10 days agoChange DetectedA new revision entry v3.5.5 is added to the record history, signaling an updated version of the study record. The prior revision v3.5.4 is removed from the history list.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedRevision label at the bottom updated from v3.5.3 to v3.5.4, reflecting a new page build. This change affects page metadata and presentation but does not alter any trial data or content.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page’s revision label changed from v3.5.2 to v3.5.3 in the footer, signaling a new release of the page’s record history. This is a minor update to the page’s versioning and does not alter the study details presented.SummaryDifference0.1%

- Check60 days agoChange DetectedThe history now shows a new revision entry (v3.5.2) and the previous revision (v3.5.0) has been removed from the version history.SummaryDifference0.1%

- Check89 days agoChange DetectedA new revision entry v3.5.0 was added to the Record History and the previous revision v3.4.3 was removed.SummaryDifference0.1%

Stay in the know with updates to Subcutaneous Atezolizumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Subcutaneous Atezolizumab in NSCLC Clinical Trial page.